Instituto de Neuroetología, Universidad Veracruzana, Av. Dr. Luis Castelazo Ayala s/n, Industrial Ánimas, Xalapa 91193, Veracruz, Mexico.
Centro de Investigaciones Biomédicas, Universidad Veracruzana, Av. Dr. Luis Castelazo Ayala s/n, Industrial Ánimas, Xalapa 91193, Veracruz, Mexico.
Nutrients. 2024 Oct 20;16(20):3560. doi: 10.3390/nu16203560.
BACKGROUND/OBJECTIVE: Obesity, clinically defined as a body mass index (BMI) of 30 kg/m or higher, is a medical condition characterized by the excessive accumulation of body fat, which can lead to adverse health consequences. As a global public health issue with an escalating prevalence, controlling appetite and satiety is essential for regulating energy balance and managing body weight. Dietary proteins and peptides have gained interest in their potential to prevent and treat obesity by modulating satiety signals. This narrative review analyzes scientific evidence highlighting the role of dietary proteins and peptides in regulating satiety signals and investigates their therapeutic potential in preventing and treating obesity.
A comprehensive literature search was conducted in multiple electronic databases, including PubMed, Scopus, and Web of Science. The search focused on articles examining the impact of dietary proteins and peptides on satiety and obesity, encompassing both preclinical and clinical trials.
Several studies have demonstrated a correlation between the intake of specific proteins or peptides from plant and animal sources and satiety regulation. These investigations identified mechanisms where amino acids and peptides interact with enteroendocrine cell receptors, activating intracellular signaling cascades that promote the release of anorexigenic gut hormones such as cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide YY (PYY). Both in vitro and in vivo assays have shown that these interactions contribute to appetite regulation and the sensation of satiety.
Using proteins and peptides in the diet may be an effective strategy for regulating appetite and controlling body weight. However, more research-including clinical trials-is needed to understand the underlying mechanisms better and optimize the application of these bioactive compounds in preventing and treating obesity.
背景/目的:肥胖,临床上定义为体质量指数(BMI)≥30kg/m²,是一种身体脂肪过度积累的疾病状态,可导致不良的健康后果。作为一种呈上升趋势流行的全球公共卫生问题,控制食欲和饱腹感对于调节能量平衡和管理体重至关重要。膳食蛋白质和肽因其调节饱腹感信号的潜力而受到关注,它们可能具有预防和治疗肥胖的作用。本综述分析了强调膳食蛋白质和肽在调节饱腹感信号中的作用的科学证据,并研究了它们在预防和治疗肥胖中的治疗潜力。
在多个电子数据库(包括 PubMed、Scopus 和 Web of Science)中进行了全面的文献检索,检索重点是研究膳食蛋白质和肽对饱腹感和肥胖影响的文章,包括临床前和临床试验。
多项研究表明,特定的植物和动物来源的蛋白质或肽的摄入与饱腹感调节之间存在相关性。这些研究确定了氨基酸和肽与肠内分泌细胞受体相互作用的机制,激活细胞内信号级联反应,促进胆囊收缩素(CCK)、胰高血糖素样肽-1(GLP-1)和肽 YY(PYY)等厌食性肠道激素的释放。体外和体内试验均表明,这些相互作用有助于调节食欲和饱腹感。
在饮食中使用蛋白质和肽可能是调节食欲和控制体重的有效策略。然而,需要更多的研究,包括临床试验,以更好地了解潜在机制,并优化这些生物活性化合物在预防和治疗肥胖中的应用。